Glycopyrrolate Injection Vials Recalled Due to Labeling Mix-up
HF Acquisition Co LLC is recalling Glycopyrrolate Injection 0.2mg/mL due to a label mix-up affecting specific lots distributed in Texas, Arizona, and California.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III drug recall involving a labeling error with no reported illnesses or injuries. Per the severity rubric, minor labeling errors are typically scored as Moderate (2).
Plain-English summary
HF Acquisition Co LLC is recalling Glycopyrrolate Injection, USP 0.2mg/mL in 1mL vials because of a label mix-up. The recalled product is Lot #2205095.1, which expires July 31, 2024. The recall involves 9 boxes containing 25 vials each.
The product was distributed to Texas, Arizona, and California. Healthcare facilities and patients who have this product should contact HF Acquisition Co LLC or their distributor for instructions on return and replacement.
The recalled product
- Product
- GLYCOPYRROLATE (GLYCOPYRROLATE)
- Brand
- GLYCOPYRROLATE
- Manufacturer
- HF Acquisition Co LLC
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2205095.1
- Exp. Date 7/31/2024
Distribution
Related recalls
Same brand · GLYCOPYRROLATE
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate oral solution recalled after failing impurity and degradation specifications
FDA (Drugs) · 2026-02-04
- ModerateGlycopyrrolate Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2023-06-28
- HighGlycopyrrolate Injection Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2023-03-08
Same manufacturer · HF Acquisition Co LLC
See all →- ModerateSporeTraq 52-test mail-in spore testing service used incorrect incubation
FDA (Devices) · 2026-06-17
- ModerateSporeTraq 12-test mail-in spore testing service used incorrect incubation
FDA (Devices) · 2026-06-17
- HighSpore Test Monitoring System Printing Error May Cause Result Misdirection
FDA (Devices) · 2025-02-19
- ModerateHealthFirst STAT KIT Z-1000 Emergency Medical Kits Recalled for Missing Component
FDA (Devices) · 2020-08-19
- ModerateHF Acquisition Recalls STAT KIT 550 Emergency Medical Kits
FDA (Devices) · 2020-08-19
Same hazard · label mix up
See all →- HighAmphetamine extended-release capsules contain immediate-release pellets after label mix-up
FDA (Drugs) · 2026-07-08
- SevereSandoz cefazolin cartons contained vials labeled as penicillin G potassium
FDA (Drugs) · 2025-07-09
- SevereBuffered penicillin G potassium vials may actually contain cefazolin for injection
FDA (Drugs) · 2025-07-09
- ModerateEye drops recalled nationwide due to labeling mix-up
FDA (Drugs) · 2025-01-08
- HighPrescription Drug Sunitinib Malate Subject to Label Mix-Up Recall
FDA (Drugs) · 2024-12-11